N/A
N=86
Examining Community-based Effectiveness of a Substance Use and HIV Risk Reduction Intervention for Young Men of Color
Substance Use · Sexual Risk
Bottom Line
View on ClinicalTrials.gov: NCT03488914 ↗Enrolled (actual)
86
Serious AEs
0.0%
Results posted
May 2024
Primary outcome: Primary: Illicit Drug Use Days — 3.04; 11.62; 2.00; 6.04 days — p=.19
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- YMHP Intervention (Behavioral); Enhanced Treatment as Usual (Behavioral)
- Age
- Pediatric, Adult · 15+ yrs
- Sex
- Male
- Sponsor
- Hunter College of City University of New York
- Primary completion
- Apr 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Illicit Drug Use Days |
3.04; 11.62; 2.00; 6.04; 1.19; 6.29 | .19 |
| PRIMARY Condomless Anal Sex Acts |
10.38; 14.36; 9.71; 9.47; 3.38; 11.14 | .96 |
| PRIMARY Marijuana Use Days |
33.11; 46.15; 34.19; 44.39; 35.81; 24.50 | .54 |
| SECONDARY Alcohol Use Days |
20.26; 30.10; 18.81; 27.04; 9.94; 20.29 | .31 |
Summary
This study will conduct an effectiveness trial of the 4-session evidence-based YMHP intervention for young men who have sex with men (YMSM) of color ages 15-29 at two CBOs in New York City, compared to usual care.
Eligibility Criteria
Inclusion Criteria
- HIV-negative test result from the past 90 days
- 15-29 years of age
- Born biologically male or currently identifying as male
- Sex with men in the past 90 days
- ≥ 5 days of illicit drug use in the past 90 days
- ≥ 1 episode of condomless anal sex (CAS) in the past 90 days, or a positive sexually transmitted infection test result in the past 90 days.
- Living in the New York City area
- Able to communicate in English
Exclusion Criteria
- Serious cognitive or psychiatric impairments
- ≥5 days of injection drug use in the past 90 days
- Currently taking Truvada as Pre-Exposure Prophylaxis (PrEP)
Data sourced from ClinicalTrials.gov (NCT03488914). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.